Industry News

Arkema Announces Full Year 2007 Sales

Published on 2008-02-20. Author : SpecialChem

Paris -- Arkema's full year 2007 sales stood at €5,675 million, slightly up on its 2006 sales of €5,664 million, a 4% increase excluding foreign exchange rate effect and variations in the scope of business. This increase resulted from a sound organic growth in volumes (+2.3%) sustained in particular by the development of Arkema's activities in Asia and by targeted projects in North America and in Europe (unit extensions in Industrial Chemicals and launch of new products in Performance Products). This improvement is also due to Arkema's ongoing policy to selectively increase its sales prices (+1.7%) across its three business segments in order to offset the impact of raw material and energy price rises.

The impact on sales of the conversion effect, due primarily to the decline in the US dollar versus euro conversion rate, stood at -2.6%. Variations in the scope of business resulting in particular from portfolio management (acquisition of Coatex, and divestment of Amines in the United States as well as Urea Formaldehyde Resins) had a negative impact of 1.2% on sales. In the 4th quarter, the change in the sales consolidation method for some subsidiaries resulted in a €29 million decrease in Performance Products sales.

About Arkema:

A global chemical player, Arkema consists of 3 coherent and related business segments: Vinyl Products, Industrial Chemicals, and Performance Products. Present in over 40 countries with 17,000 employees, Arkema achieves sales of 5.7 billion euros. With its 6 research centers in France, the United States and Japan, and internationally recognized brands, Arkema holds leadership positions in its principal markets.


The information disclosed in this press release may contain forward-looking statements with respect to the financial condition, results of operations, business and strategy of ARKEMA. Such statements are based on Management's current views and assumptions that could ultimately prove inaccurate and are subject to risk factors such as, among others, changes in raw materials prices, currency fluctuations, implementation pace of cost-reduction projects and changes in general economic and business conditions.

ARKEMA does not assume any liability to update such forward-looking statements whether as a result of any new information or any unexpected event or otherwise. Further information on factors which could affect ARKEMA's financial results is provided in the documents filed with the French Autorité des Marchés Financiers.

Financial information for 2006 and 2007 is extracted from the consolidated financial statements of Arkema. The business segment information is presented in accordance with ARKEMA's internal reporting system used by the Management.

Source: Arkema

Omya Calcium Carboantes
Back to Top